| Dr Marianne J Suprys, MD | |
|
210 N Mercer St, Linesville, PA 16424-9232 | |
| (814) 683-2014 | |
| Not Available |
| Full Name | Dr Marianne J Suprys |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 37 Years |
| Location | 210 N Mercer St, Linesville, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306849625 | NPI | - | NPPES |
| 0012040880004 | Medicaid | PA | |
| 20047 FCN | Other | PA | EPSDT |
| E65436 | Other | PA | HEALTH AMERICA |
| 122811 | Other | PA | UNISON HEALTH PLAN |
| 205047 | Other | PA | UPMC HEALTH PLAN |
| 0012040880007 | Medicaid | PA | |
| 080084839 | Other | PA | PALMETTO GBA-RAILROAD MEDICARE |
| 251754199019 | Other | PA | MEDICAL MUTUAL OF OHIO |
| 902560 | Other | PA | HIGHMARK BLUE CROSS BLUE SHIELD |
| 4235190002 | Other | PA | NATIONAL SUPPLIERS CLEARINGHOUSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD042437E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vna Alliance | Meadville, PA | Home health agency |
| Lakeland Area Hospice, Lp | Erie, PA | Hospice |
| Aseracare Hospice | Erie, PA | Hospice |
| Hospice Of Crawford Cnty Inc | Meadville, PA | Hospice |
| Meadville Medical Center | Meadville, PA | Hospital |
| Titusville Hospital | Titusville, PA | Hospital |
| Upmc Horizon | Greenville, PA | Hospital |
| Rolling Fields, Inc | Conneautville, PA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Primary Care Services | 0244452258 | 18 |
| Titusville Area Hospital | 8022907575 | 60 |
News Archive
EraGen Biosciences Inc., a developer of novel molecular reagents for the in-vitro diagnostics (IVD) market, and Illumina Inc., a global company that develops, manufactures and markets integrated systems for analysis of genetic variation and biological function, today announced the formation of a strategic partnership and the execution of non-exclusive licensing agreements.
On Friday, B.C.'s last centre offering intensive autism treatment for children under 6 closed its doors. The provincial government had cancelled all funding, eliminated 42 jobs and cut adrift all the children currently being treated and all those on the waiting list.
Figures released Friday reflect the number of participants in the health overhaul's high-risk pools as of April. Meanwhile, Modern Healthcare reports that Kansas has widened it's high-risk pool to allow child-only plans.
A coalition of AIDS organizations is asking the Obama administration to investigate whether some insurers are trying to discourage HIV-infected patients from enrolling in their policies by failing to cover some AIDS drugs or through what it called "egregious cost-sharing designs." Other stories explore the law's impact on African-Americans and small businesses.
Novartis announced today that the US Food and Drug Administration has granted priority review for LCZ696, an investigational medicine for the treatment of heart failure with reduced ejection fraction (HFrEF). The designation is intended to accelerate the review of therapies that offer a significant improvement in the safety or effectiveness of the treatment, prevention or diagnosis of a serious condition.
› Verified 8 days ago
| Entity Name | Primary Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962804955 PECOS PAC ID: 0244452258 Enrollment ID: O20141106001537 |
News Archive
EraGen Biosciences Inc., a developer of novel molecular reagents for the in-vitro diagnostics (IVD) market, and Illumina Inc., a global company that develops, manufactures and markets integrated systems for analysis of genetic variation and biological function, today announced the formation of a strategic partnership and the execution of non-exclusive licensing agreements.
On Friday, B.C.'s last centre offering intensive autism treatment for children under 6 closed its doors. The provincial government had cancelled all funding, eliminated 42 jobs and cut adrift all the children currently being treated and all those on the waiting list.
Figures released Friday reflect the number of participants in the health overhaul's high-risk pools as of April. Meanwhile, Modern Healthcare reports that Kansas has widened it's high-risk pool to allow child-only plans.
A coalition of AIDS organizations is asking the Obama administration to investigate whether some insurers are trying to discourage HIV-infected patients from enrolling in their policies by failing to cover some AIDS drugs or through what it called "egregious cost-sharing designs." Other stories explore the law's impact on African-Americans and small businesses.
Novartis announced today that the US Food and Drug Administration has granted priority review for LCZ696, an investigational medicine for the treatment of heart failure with reduced ejection fraction (HFrEF). The designation is intended to accelerate the review of therapies that offer a significant improvement in the safety or effectiveness of the treatment, prevention or diagnosis of a serious condition.
› Verified 8 days ago
| Entity Name | Titusville Area Hospital |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1962964981 PECOS PAC ID: 8022907575 Enrollment ID: O20190603002047 |
News Archive
EraGen Biosciences Inc., a developer of novel molecular reagents for the in-vitro diagnostics (IVD) market, and Illumina Inc., a global company that develops, manufactures and markets integrated systems for analysis of genetic variation and biological function, today announced the formation of a strategic partnership and the execution of non-exclusive licensing agreements.
On Friday, B.C.'s last centre offering intensive autism treatment for children under 6 closed its doors. The provincial government had cancelled all funding, eliminated 42 jobs and cut adrift all the children currently being treated and all those on the waiting list.
Figures released Friday reflect the number of participants in the health overhaul's high-risk pools as of April. Meanwhile, Modern Healthcare reports that Kansas has widened it's high-risk pool to allow child-only plans.
A coalition of AIDS organizations is asking the Obama administration to investigate whether some insurers are trying to discourage HIV-infected patients from enrolling in their policies by failing to cover some AIDS drugs or through what it called "egregious cost-sharing designs." Other stories explore the law's impact on African-Americans and small businesses.
Novartis announced today that the US Food and Drug Administration has granted priority review for LCZ696, an investigational medicine for the treatment of heart failure with reduced ejection fraction (HFrEF). The designation is intended to accelerate the review of therapies that offer a significant improvement in the safety or effectiveness of the treatment, prevention or diagnosis of a serious condition.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marianne J Suprys, MD 1012 Water St, Meadville, PA 16335-3444 Ph: (814) 336-5995 | Dr Marianne J Suprys, MD 210 N Mercer St, Linesville, PA 16424-9232 Ph: (814) 683-2014 |
News Archive
EraGen Biosciences Inc., a developer of novel molecular reagents for the in-vitro diagnostics (IVD) market, and Illumina Inc., a global company that develops, manufactures and markets integrated systems for analysis of genetic variation and biological function, today announced the formation of a strategic partnership and the execution of non-exclusive licensing agreements.
On Friday, B.C.'s last centre offering intensive autism treatment for children under 6 closed its doors. The provincial government had cancelled all funding, eliminated 42 jobs and cut adrift all the children currently being treated and all those on the waiting list.
Figures released Friday reflect the number of participants in the health overhaul's high-risk pools as of April. Meanwhile, Modern Healthcare reports that Kansas has widened it's high-risk pool to allow child-only plans.
A coalition of AIDS organizations is asking the Obama administration to investigate whether some insurers are trying to discourage HIV-infected patients from enrolling in their policies by failing to cover some AIDS drugs or through what it called "egregious cost-sharing designs." Other stories explore the law's impact on African-Americans and small businesses.
Novartis announced today that the US Food and Drug Administration has granted priority review for LCZ696, an investigational medicine for the treatment of heart failure with reduced ejection fraction (HFrEF). The designation is intended to accelerate the review of therapies that offer a significant improvement in the safety or effectiveness of the treatment, prevention or diagnosis of a serious condition.
› Verified 8 days ago
Dr. Elizabeth Oven, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 210 N Mercer St, Linesville, PA 16424 Phone: 814-683-4636 Fax: 814-683-5869 |